email-header_MPNHeroes
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
09. Dezember 2023 00:00 ET | CURE Media Group
CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients,...
Jane Fonda
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program
16. November 2023 10:38 ET | CURE Media Group
CURE and Incyte Corporation are proud to host the 2023 MPN Heroes recognition ceremony, an evening of gratitude and celebration of the heroes who have made a significant impact in the lives of...
Graphic with event information for 2022 MPN Heroes, accompanied by a photo of keynote speaker Vanessa Bayer
CURE Media Group announces winners of the 2022 MPN Heroes Recognition Program
09. Dezember 2022 11:00 ET | CURE Media Group
CRANBURY, N.J., Dec. 09, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to the more than one million patients,...
Graphic with a photo of keynote speaker Vanessa Bayer with information about the MPN Heroes event
CURE Media Group announces Vanessa Bayer as keynote speaker for the 2022 MPN Heroes® Recognition Program 
02. Dezember 2022 17:41 ET | CURE Media Group
CRANBURY, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to the more than one million patients,...
Sole 2 Soul for MPN™ logo
Inaugural Sole 2 Soul for MPN™ Trek Set For August 3-7, 2022 in Waterton Lakes National Park in Canada
03. August 2022 08:01 ET | CURE Media Group
CRANBURY, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than 1 million patients,...
MPN Research Foundation
3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation
01. November 2021 08:45 ET | MPN Research Foundation
Chicago, IL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In real-world usage and in clinical trials, interferon (IFN) in a variety of forms has shown high rates of hematologic and molecular responses in many...